Market revenue in 2024 | USD 89.6 million |
Market revenue in 2030 | USD 101.2 million |
Growth rate | 2.1% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 53.91% in 2024. Horizon Databook has segmented the Saudi Arabia hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
Key multinational companies such as bioMérieux, BD (Becton, Dickinson and Company), and Roche Diagnostics hold significant market shares, leveraging their extensive product portfolios and robust distribution networks.
Local competitors, including Saudi-based medical distributors and diagnostic service providers, also contribute to the competitive landscape by offering cost-effective solutions tailored to local healthcare needs.
Recent developments include partnerships between multinational corporations and local firms to enhance market penetration and ensure compliance with local regulations. Global players are increasingly focusing on innovative diagnostic technologies, such as molecular assays and rapid testing kits, to address the growing demand for early detection of HAIs.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account